Document is current
Any future updates will be listed below
-
Authors
Ravera, Francesco
Borea, Roberto
Cirmena, Gabriella
Dameri, Martina
Ferrando, Lorenzo
Gallo, Maurizio
Casini, Cecilia
Fallani, Neri
Stabile, Mario
Barbero, Valentina
Murialdo, Roberto
Tixi, Lucia
Cappuccio, Margherita
Cuboni, Andrea
Sivieri, Irene
Fornarini, Giuseppe
De Maria, Andrea
Ballestrero, Alberto
Zoppoli, Gabriele https://orcid.org/0000-0002-1619-1708
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (21761)
IRCCS Ospedale Policlinico San Martino
Università degli Studi di Genova
- License Information
-
More Information
Article History
Received: 12 January 2022
Accepted: 5 May 2022
First Online: 14 May 2022
Declarations
:
: This study was approved by the local Ethics Committee (Comitato Etico Regione Liguria, reference number: 10575). Written informed consents were obtained from all study participants, and all methods were carried out in accordance with relevant guidelines and regulations.
: Not Applicable.
: GZ received consulting fees from Novartis, travel grants from Novartis, Pfizer, and Roche, and research reagents from Cytiva and ThermoFisher Scientific. The other Authors report no conflict of interest.
